Daniela P Lage Selected Research

Chagas Disease (American Trypanosomiasis)

5/2024	A recombinant chimeric antigen constructed with B-cell epitopes from Mycobacterium leprae hypothetical proteins is effective for the diagnosis of leprosy.
3/2024	Serodiagnosis of paucibacillary and multibacillary leprosy using a recombinant chimeric protein composed of specific B-cell epitopes derived from Mycobacterium leprae proteins.
12/2021	Potential of recombinant LiHyQ, a novel Leishmania infantum protein, for the diagnosis of canine visceral leishmaniasis and as a diagnostic and prognostic marker for human leishmaniasis and human immunodeficiency virus co-infection: A preliminary study.
1/2013	Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniela P Lage Research Topics

Disease

53	Visceral Leishmaniasis (Kala Azar) 05/2024 - 01/2013
35	Infections 03/2024 - 06/2013
26	Leishmaniasis 03/2024 - 01/2014
4	Chagas Disease (American Trypanosomiasis) 05/2024 - 01/2013
4	Coinfection 12/2021 - 01/2020
3	Tuberculosis (Tuberculoses) 05/2024 - 12/2021
3	Leprosy (Hansen's Disease) 05/2024 - 12/2021
2	Malaria 05/2024 - 03/2024
2	HIV Infections (HIV Infection) 12/2021 - 11/2021
2	Neglected Diseases 06/2020 - 01/2020
1	Aspergillosis 05/2024
1	Histoplasmosis 05/2024
1	Multibacillary Leprosy 03/2024
1	Edema (Dropsy) 01/2023
1	COVID-19 01/2023
1	Drug-Related Side Effects and Adverse Reactions 02/2022
1	Paracoccidioidomycosis (South American Blastomycosis) 12/2021
1	Parasitic Diseases (Parasitic Disease) 02/2021
1	Heart Diseases (Heart Disease) 01/2021
1	Necrosis 01/2019
1	Disease Progression 01/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2016
1	Albuminuria 01/2016

Drug/Important Bio-Agent (IBA)

50	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2013
21	VaccinesIBA 01/2023 - 01/2013
14	AntigensIBA 05/2024 - 01/2014
12	Recombinant ProteinsIBA 05/2024 - 01/2018
11	MicellesIBA 03/2024 - 10/2016
11	AntibodiesIBA 01/2023 - 01/2013
8	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 05/2024 - 01/2019
7	Recombinant Fusion ProteinsIBA 05/2024 - 01/2017
6	Peptides (Polypeptides)IBA 05/2024 - 06/2013
6	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023 - 01/2018
5	SaponinsIBA 12/2023 - 07/2017
5	Immunoglobulin G (IgG)IBA 01/2023 - 01/2018
5	Interleukin-12 (IL 12)IBA 01/2023 - 10/2018
4	Amphotericin B (Amphotericin)FDA LinkGeneric 10/2023 - 10/2016
4	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 07/2022 - 10/2018
4	EpitopesIBA 11/2021 - 01/2014
4	Interleukin-10 (Interleukin 10)IBA 01/2019 - 01/2016
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2016
3	vanillinIBA 03/2024 - 08/2023
3	CytokinesIBA 01/2023 - 01/2016
3	NitritesIBA 01/2023 - 01/2018
3	Pyridoxal KinaseIBA 12/2020 - 01/2020
3	DNA VaccinesIBA 12/2020 - 01/2018
3	Interleukin-4 (Interleukin 4)IBA 01/2019 - 01/2018
2	Ivermectin (Mectizan)FDA Link 01/2023 - 02/2021
2	NaphthoquinonesIBA 02/2022 - 01/2019
2	Poloxamer (Poloxamer 407)IBA 01/2022 - 10/2016
2	A-Form DNA (A-DNA)IBA 02/2021 - 01/2019
2	Virulence Factors (Pathogenicity Factors)IBA 02/2021 - 01/2018
2	CardenolidesIBA 01/2021 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 01/2018
2	Synthetic Vaccines (Recombinant Vaccines)IBA 06/2020 - 01/2020
2	Liposomes (Liposome)IBA 06/2020 - 11/2018
2	Peptide Initiation Factors (Initiation Factor)IBA 01/2020 - 01/2016
2	ProhibitinsIBA 01/2020 - 01/2018
2	InterferonsIBA 10/2018 - 01/2018
2	OxygenasesIBA 04/2013 - 01/2013
1	monophosphoryl lipid AIBA 10/2023
1	EndonucleasesIBA 01/2023
1	quinolineIBA 07/2022
1	SaltsIBA 07/2022
1	EnzymesIBA 06/2022
1	ImmunosorbentsIBA 06/2022
1	Guanosine Triphosphate (GTP)IBA 01/2022
1	GTP-Binding Proteins (G-Protein)IBA 01/2022
1	N 30IBA 12/2021
1	Acarbose FDA LinkGeneric 06/2021
1	Digitoxin FDA Link 01/2021
1	DigitoxigeninIBA 01/2021
1	miltefosine (Impavido)IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	UCON 50-HB-5100 (F127)IBA 01/2020
1	Clioquinol (Vioform)FDA Link 01/2020
1	Leishmania infantum amastin proteinIBA 01/2020
1	Staphylococcal Protein A (Protein A)IBA 12/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Interleukin-2 (IL2)IBA 01/2019
1	ProteomeIBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2018
1	Adenosine Monophosphate (AMP)IBA 03/2018
1	InterleukinsIBA 01/2018
1	Glutamine (L-Glutamine)FDA Link 11/2017
1	Phosphopyruvate Hydratase (Enolase)IBA 07/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Cystatin CIBA 01/2016
1	Urea (Carbamide)FDA LinkGeneric 01/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	CreatinineIBA 01/2016
1	Thiobarbituric Acid Reactive SubstancesIBA 01/2016
1	PolyproteinsIBA 01/2016
1	ThrombomodulinIBA 01/2016

Therapy/Procedure

4	Therapeutics 02/2022 - 01/2014
2	Immunotherapy 10/2023 - 06/2023
1	Aftercare (After-Treatment) 12/2019
1	Drug Therapy (Chemotherapy) 01/2018